Synthesis and cytotoxic activity of N-substituted thiosemicarbazones of 3-(3,4-methylenedioxy) phenylpropanal

Farmaco

Volumn 53, Issue 3, 1998, Pages 241-243

  Silva, Maria Joselice E ^a   Alves, Antonio José ^a   Do Nascimento, Silene C ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cytotoxic activity; Safrole; Thiosemicarbazones

Indexed keywords

3 (3,4 METHYLENEDIOXY)PHENYLPROPANAL; SAFROLE; THIOSEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG SYNTHESIS; OXIDATION; POLYMERIZATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TECHNIQUE;

EID: 0032030269     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(97)00022-0     Document Type: Article

References (13)

1. [1] M. Liu, T. Lin, A.C. Sartorelli, Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone, J. Med. Chem. 35 (1992) 3672-3677.
2. [2] A. Mignot, M. Miocque, P. Binet, J.R. Rapin, P. Rinjard, M. Roux, M.J. Cals, J.C. Ekindjian, Thiosemicarbazones d'aldéhydes aromatiques antiinflammatoires: pharmacologie, étude pharmacocinétique préliminaire, action sur le fibroblaste en culture. Eur. J. Med. Chem. 15 (1980) 33-40.
3. [3] G. Domagk, R. Benisch, F. Mietzsch, H. Schmidt, Über eine neue, gegen Tuberkelbazillen in vitro wirksame Verbindungsklasse, Naturwissenschaften 33 (1946) 315.
4. [4] J. Bernstein, H.L. Yale, K. Losee, M. Holsing, J. Martins, W.A. Lott, The chemotherapy of experimental tuberculosis. III. The synthesis of thiosemicarbazones and related compounds, J. Am. Chem. Soc. 73 (1951) 906-912.
5. [5] Y. Teytz, D. Ronen, A. Vansover, T. Stematsky, J.L. Riggs, Inhibition of human immunodeficiency virus by N-methylisatin-beta 4′:4′-diethylthiosemicarbazone and N-allylisatin-beta 4′:4′-diallythiosemicarbazone, Antiviral Res. 24 (1994) 305-314.
6. [6] Y. Teytz, N. Barko, M. Abramoff, D. Ronen, Relationships between structure and antiretroviral activity of thiosemicarbazone derivatives, Chemotherapy 40 (1994) 195-200.
7. [7] I.H. Hall, O.T. Wong, J.M. Chapman, Cytotoxicity of imides-N-alkyl semicarbazones, thiosemicarbazones, acetylhydrazones and related derivatives, Anticancer Drugs 6 (1995) 147-153.
8. [8] E.M. Acton, R.N. Goerner, H.S. Uh, K.J. Ryan, D.W. Henry, Improved antitumor effects in 3′-branched homologues of 2′-deoxythioguanosine. Synthesis and evaluation of thioguanine nucleosides of 2,3-dideoxy-3-(hydroxymethyl)-D-erythro-pentofuranose, J. Med. Chem. 22 (1979) 518-525.
9. [9] E.J. Corey, G. Schmidt, Useful procedures for the oxidation of alcohols involving pyridinium dichromate in aprotic media, Tetrahedron Lett. 5 (1979) 399-402.
10. [10] H. Eagle, Propagation in a fluid medium of a human epidermoide carcinoma, strain KB. (21811), Proc. Soc. Exp. Biol. Med. 89 (1955) 362-364.
11. [11] H. Eagle, Amino acid metabolism in mammalian cell cultures, Science 130 (1959) 432-137.
12. [12] R.I. Geran, N.H. Greenberg, M.M. Macdonald, A.M. Schumacher, B.J. Abbott, Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Can. Chem. Rep. 3 (1972) 1-88.
13. [13] V.I. Oyama, H. Eagle, Measurement of cell growth in tissue culture with a phenol reagent (Folin-ciocalteus), Proc. Soc. Exp. Biol. Med. 91 (1956) 305-307.